Synthesis and Anti-inflammatory Activity of Some New 6-Aryltriazolo[3,4-b][1,3,4]thiadiazole Derivatives
DOI:
https://doi.org/10.24959/ophcj.24.321751Keywords:
[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole, anti-inflammatory activity, cyclooxygenase, dockingAbstract
A series of 6-aryl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives has been synthesized. Their anti-inflammatory activity has been studied in vivo in a carrageenan model of the paw inflammatory edema in rats. 3-(2-Fluorophenyl)-6-phenyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole (3c) and 3-(2-fluorophenyl)-6-(4-methoxy-phenyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole (3d) have been identified as hit compounds with the anti-exudative activity. The crucial role of the fluorine atom in the anti-inflammatory activity has been determined, which value considerably correlates with the calculated values of lipophilicity and solubility.
Supporting Agency
- The author received no specific funding for this work.
Downloads
References
- Gusev, E.; Zhuravleva, Y. Inflammation: A New Look at an Old Problem. Int. J. Mol. Sci. 2022, 23, 4596. https://doi.org/10.3390/ijms23094596.
|
|
- Tai, F. W. D.; McAlindon, M. E. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Clinical Medicine 2021, 21 (2), 131-134. https://doi.org/10.7861/clinmed.2021-0039.
|
|
- Mitsis, A.; Avraamides, P.; Lakoumentas, J.; Kyriakou, M.; Sokratous, S.; Karmioti, G.; Drakomathioulakis, M.; Theodoropoulos, K. C.; Nasoufidou, A.; Evangeliou, A.; Vassilikos, V.; Fragakis, N.; Ziakas, A.; Tzikas, S.; Kassimis, G. Role of Inflammation Following An Acute Myocardial Infarction: Design of INFINITY. Biomarkers in Medicine. 2023, 17 (23), 971-981. https://doi.org/10.2217/bmm-2023-0491.
|
|
- Aggarwal, R.; Sumran, G. An insight on medicinal attributes of 1,2,4-triazoles. Eur. J. Med. Chem. 2020, 205, 112652. https://doi.org/10.1016/j.ejmech.2020.112652.
|
|
- Bozorov, K.; Zhao, J.; Aisa, H. A. 1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview. Bioorg. Med. Chem. 2019, 27 (16), 3511-3531. https://doi.org/10.1016/j.bmc.2019.07.005.
|
|
- Iraji, A.; Firuzi, O.; Khoshneviszadeh, M.; Tavakkoli, M.; Mahdavi, M.; Nadri, H.; Edraki, N.; Miri, R. Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease. Eur. J. Med. Chem. 2017, 141, 690-702. https://doi.org/10.1016/j.ejmech.2017.09.057.
|
|
- Li, Y.; Geng, J.; Liu, Y.; Yu, S.; Zhao, G. Thiadiazole—a Promising Structure in Medicinal Chemistry. ChemMedChem. 2013, 8 (1), 27-41. https://doi.org/10.1002/cmdc.201200355.
|
|
- Khalili Ghomi, M.; Noori, M.; Nazari Montazer, M.; Zomorodian, K.; Dastyafteh, N.; Yazdanpanah, S.; Sayahi, M. H.; Javanshir, S.; Nouri, A.; Asadi, M.; Badali, H.; Larijani, B.; Irajie, C.; Iraji, A.; Mahdavi, M. [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as new therapeutic candidates against urease positive microorganisms: design, synthesis, pharmacological evaluations, and in silico studies. Scientific reports 2023, 13 (1), 10136. https://doi.org/10.1038/s41598-023-37203-z.
|
|
- Mathew, V.; Keshavayya, J.; Vaidya, V. P.; Giles, D. Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues. Eur. J. Med. Chem. 2007, 42 (6), 823-840. https://doi.org/10.1016/j.ejmech.2006.12.010.
|
|
- Gilani, S. J.; Khan, S. A.; Siddiqui, N. Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid. Bioorg. Med. Chem. Lett. 2010, 20 (16), 4762-4765. https://doi.org/10.1016/j.bmcl.2010.06.125.
|
|
- Zhang, L.; Zhao, J.; Zhang, B.; Lu, T.; Chen, Y. Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity. Eur. J. Med. Chem. 2018, 150, 809-816. https://doi.org/10.1016/j.ejmech.2018.03.049.
|
|
- Chidananda, N.; Poojary, B.; Sumangala, V.; Kumari, N. S.; Shetty, P.; Arulmoli, T. Facile Synthesis, Characterization and Pharmacological Activities of 3,6-Disubstituted 1,2,4-Triazolo[3,4-b][1,3,4]Thiadiazoles and 5,6-Dihydro-3,6-Disubstituted-1,2,4-Triazolo[3,4-b][1,3,4]Thiadiazoles. Eur. J. Med. Chem. 2012, 51, 124–136. https://doi.org/10.1016/j.ejmech.2012.02.030.
|
|
- Al-Wahaibi, L. H.; Karthikeyan, S.; Blacque, O.; El-Masry, A. A.; Hassan, H. M.; Percino, M. J.; El-Emam, A. A.; Thamotharan, S. Structural and Energetic Properties of Weak Noncovalent Interactions in Two Closely Related 3,6-Disubstituted-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole Derivatives: In Vitro Cyclooxygenase Activity, Crystallography, and Computational Investigations. ACS Omega 2022, 7 (38), 34506-34520. https://doi.org/10.1021/acsomega.2c04252.
|
|
- Maddila, S.; Gorle, S.; Singh, M.; Lavanya, P.; Jonnalagadda, S. B. Synthesis and Anti-Inflammatory Activity of Fused 1,2,4-triazolo-[3,4-b] [1,3,4]thiadiazole Derivatives of Phenothiazine. Letters in Drug Design & Discovery 2013, 10 (10), 977-983. http://dx.doi.org/10.2174/15701808113109990034.
|
- Birsen, T.; Sevim Peri, A.; Sule, G.; Selami, G.; Goknur, A. Novel 1,2,4-Triazolo[3,4-b]-1,3,4-thiadiazole Derivatives as Dual Analgesic/Anti-inflammatory and Antimicrobial Agents. Letters in Drug Design & Discovery 2012, 9 (2), 204-212. http://dx.doi.org/10.2174/157018012799079626.
|
- Apan, A.; Casoni, D.; Leonte, D.; Pop, C.; Iaru, I.; Mogoșan, C.; Zaharia, V. Heterocycles 52: The Drug-Likeness Analysis of Anti-Inflammatory Thiazolo[3,2-b][1,2,4]triazole and Imidazo[2,1-b][1,3,4]thiadiazole Derivatives. Pharmaceuticals 2024, 17, 295. https://doi.org/10.3390/ph17030295.
|
|
- Pathak, P.; Shukla, P. K.; Naumovich, V.; Grishina, M.; Verma, A.; Potemkin, V. 1,2,4-Triazole-conjugated 1,3,4-thiadiazole hybrid scaffolds: A potent ameliorant of carrageenan-induced inflammation by lessening proinflammatory mediators. Arch. Pharm. 2020, 353 (1), 1900233. https://doi.org/10.1002/ardp.201900233.
|
|
- Tratrat, C.; Haroun, M.; Paparisva, A.; Kamoutsis, C.; Petrou, A.; Gavalas, A.; Eleftheriou, P.; Geronikaki, A.; Venugopala, K.N.; Kochkar, H.; et al. New Substituted 5-Benzylideno-2-Adamantylthiazol[3,2-b][1,2,4]Triazol-6(5H)ones as Possible Anti-Inflammatory Agents. Molecules 2021, 26, 659. https://doi.org/10.3390/molecules26030659.
|
|
- Atta-ur-Rahman, Choudhary, M. I.; Thomsen, W. J. Bioassay techniques for drug development. Harwood academic Publishers, 2005, 203 р.
- Chawla, G.; Kumar, U.; Bawa, S.; Kumar, J. Syntheses and evaluation of anti-inflammatory, analgesic and ulcerogenic activities of 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives. J. Enzyme Inhib. Med. Chem. 2012, 27 (5), 658-665. https://doi.org/10.3109/14756366.2011.606543.
|
|
- Luan, M. Z.; Zhang, X. F.; Yang, Y.; Meng, Q. G.; Hou, G. G. Anti-inflammatory activity of fluorine-substituted benzo[h]quinazoline-2-amine derivatives as NF-κB inhibitors. Bioorg. Chem. 2023, 132, 106360. https://doi.org/10.1016/j.bioorg.2023.106360.
|
|
- Kalkhambkar, R. G.; Kulkarni, G. M.; Kamanavalli, C. M.; Premkumar, N.; Asdaq, S. M.; Sun, C. M. Synthesis and biological activities of some new fluorinated coumarins and 1-aza coumarins. Eur. J. Med. Chem. 2008, 43 (10), 2178-2188. https://doi.org/10.1016/j.ejmech.2007.08.007.
|
|
- Kaur, K.; Kumar, V.; Gupta, G. K. Trifluoromethylpyrazoles as anti-inflammatory and antibacterial agents: A review. J. Fluor. Chem. 2015, 178, 306-326. https://doi.org/10.1016/j.jfluchem.2015.08.015.
|
- Nargund, L. V.; Hariprasad, V.; Reedy, G. R. Synthesis and anti-inflammatory activity of fluorinated phenyl styryl ketones and N-phenyl-5-substituted aryl-3-p-(fluorophenyl) pyrazolins and pyrazoles. J. Pharm. Sci. 1992, 81 (9), 892-894. https://doi.org/10.1002/jps.2600810910.
|
|
- Ali, S.; Bolinger, A. A.; Zhou, J. Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023. Curr. Top. Med. Chem. 2024, 24 (10), 843-849. https://doi.org/10.2174/0115680266300245240223070242.
|
|
- Wang, Q.; Bian, Y.; Dhawan, G.; Zhang, W.; Sorochinsky, A. E.; Makarem, A.; Soloshonok, V. A.; Han J. FDA approved fluorine-containing drugs in 2023. Chin. Chem. Lett. 2024, 35 (11), 109780, https://doi.org/10.1016/j.cclet.2024.109780.
|
- Sheikhi, N.; Bahraminejad, M.; Saeedi, M.; Mirfazli, S. S. A review: FDA-approved fluorine-containing small molecules from 2015 to 2022. Eur. J. Med. Chem. 2023, 260, 115758. https://doi.org/10.1016/j.ejmech.2023.115758.
|
|
- Chandra, G.; Singh, D. V.; Mahato, G. K.; Patel, S. Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs. Chemical Papers 2023, 77 (8), 4085-4106. https://doi.org/10.1007/s11696-023-02804-5.
|
|
- Henary, E.; Casa, S.; Dost, T.L.; Sloop, J.C.; Henary, M. The Role of Small Molecules Containing Fluorine Atoms in Medicine and Imaging Applications. Pharmaceuticals 2024, 17, 281. https://doi.org/10.3390/ph17030281.
|
|
- Delaney, J. S. ESOL: estimating aqueous solubility directly from molecular structure. J. Chem. Inf. Comput. Sci. 2004, 44 (3), 1000-1005. https://doi.org/10.1021/ci034243x.
|
|
- SwissADME. http://www.swissadme.ch/index.php (accessed Sep 13, 2024).
- Autodock Vina. https://vina.scripps.edu/ (accessed Jun 21, 2024).
- Discovery Studio. https://discover.3ds.com/discovery-studio-visualizer-download (accessed Jun 26, 2024).
- Kamboj, V. K.; Kapoor, A.; Jain, S. Synthesis, Antimicrobial, and Antioxidant Screening of Aryl Acetic Acid Incorporated 1,2,4-Triazolo-1,3,4-Thiadiazole Derivatives. J. Heterocycl. Chem. 2019, 56 (4), 1376-1382. https://doi.org/10.1002/jhet.3513.
|
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 National University of Pharmacy

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).